Company Filing History:
Years Active: 1996-2003
Title: Innovations of Jean-Christope Renauld
Introduction
Jean-Christope Renauld is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly in the identification and treatment of cellular abnormalities. With a total of 4 patents, his work has implications for both therapeutic and diagnostic applications.
Latest Patents
Renauld's latest patents include a method for identifying individuals suffering from a cellular abnormality, specifically those whose abnormal cells present complexes of human leukocyte antigen (HLA) and tyrosinase-derived peptides. This invention focuses on the therapeutic and diagnostic ramifications of these complexes on the surfaces of abnormal cells. Another patent addresses the identification of these complexes and their diagnostic implications, further enhancing the understanding of cellular abnormalities.
Career Highlights
Renauld is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research. His work has been pivotal in exploring the relationship between HLA molecules and cancer, contributing to the development of targeted therapies.
Collaborations
Some of his notable coworkers include Thierry R Boon-Falleur and Vincent Brichard, who have collaborated with him on various research projects.
Conclusion
Jean-Christope Renauld's innovative work in cancer research exemplifies the importance of identifying and treating cellular abnormalities. His patents reflect a commitment to advancing medical science and improving patient outcomes.